Rejuvenate Biomed
PrivateLast Round
Series B
Oct 12, 2021
Total Funding Raised
$23.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rejuvenate Biomed operates in Healthcare & Life Sciences and is based in Diepenbeek. Its latest recorded funding round was a Series B round in October 2021.
Rejuvenate Biomed is a biotechnology company that develops combination drugs to treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuvenate Biomed Comparables
Compare Rejuvenate Biomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biophytis SA | 82% | |
| Sen-Jam Pharmaceutical | 79% | |
| BioAge Labs | 76% |
For institutional investors. Book with your work email.
Rejuvenate Biomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 12, 2021 | ||||
| Series A | Mar 2, 2021 | ||||
| Grant | Aug 10, 2018 | ||||
| Accelerator | Mar 1, 2018 | ||||
| Seed | Nov 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rejuvenate Biomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vesalius Biocapital Partners | Series B |
| VLAIO | Series A, Grant |
| Johnson & Johnson Innovation - JLABS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 155% MoM.
- Aug 20, 2026
Monthly visitors increased 745% MoM.
For institutional investors. Book with your work email.
Rejuvenate Biomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rejuvenate Biomed's valuation, stock price, and market status.
Is Rejuvenate Biomed a public or private company?
Rejuvenate Biomed is a private company.
What is the current stock price of Rejuvenate Biomed?
Rejuvenate Biomed is a private company, so its shares have no public market price. Caplight tracks Rejuvenate Biomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rejuvenate Biomed worth (valuation)?
Valuation information for Rejuvenate Biomed is not publicly available.
Can I buy Rejuvenate Biomed stock?
Rejuvenate Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rejuvenate Biomed's last funding round?
Rejuvenate Biomed's most recent funding round was Series B on October 12, 2021.
Who are the main investors in Rejuvenate Biomed?
Key investors in Rejuvenate Biomed include Vesalius Biocapital Partners.
Will Rejuvenate Biomed IPO soon?
No public IPO plans have been announced for Rejuvenate Biomed.
How can I track Rejuvenate Biomed secondary market activity?
Caplight tracks bids, offers, and trades in Rejuvenate Biomed's shares on secondary markets.